Nestlé on Wednesday completed the sale of its remaining shares in Alcon to Novartis, representing around 52% of Alcon’s share capital, for USD 28.3 billion.Nestlé acquired Alcon in 1977 for USD...

Proceeds from the sale of Nestlé’s remaining stake in Alcon to health-care giant Novartis are likely to be used for deleveraging, according to an industry analyst. The Swiss food giant announced...